$LUMO
Lumos Pharma Inc Stock $lumo

$lumo Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-K Financial Statement

#000112623419000026 Filed on March 05, 2019

Income Statement

Concept	2019 Q1	2018 Q1	2017 Q4
Revenue	$0.00	$9.900M	$10.10M
YoY Change	-100.0%	258.57%	-20.51%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$700.0K	$8.300M	$5.600M
YoY Change	-91.57%	1.22%	-22.22%
% of Gross Profit
Research & Development	$1.455M	$20.31M	$16.90M
YoY Change	-92.84%	29.18%	-16.34%
% of Gross Profit
Depreciation & Amortization	$8.000K	$334.0K	$300.0K
YoY Change	-97.6%	-7.22%	-50.0%
% of Gross Profit
Operating Expenses	$2.138M	$28.61M	$22.40M
YoY Change	-92.53%	19.4%	-18.25%
Operating Profit	-$2.138M	-$18.71M	-$14.05M
YoY Change	-88.57%	-11.76%	0.58%
Interest Expense	$0.00	$13.00K	$300.0K
YoY Change	-100.0%	-87.74%	200.0%
% of Operating Profit
Other Income/Expense, Net	$33.00K	$396.0K	$0.00
YoY Change	-91.67%	-1684.0%	-100.0%
Pretax Income	-$2.105M	-$18.31M	-$13.80M
YoY Change	-88.5%	-13.73%	0.0%
Income Tax	$0.00	$0.00	-$100.0K
% Of Pretax Income
Net Earnings	-$2.105M	-$18.31M	-$13.69M
YoY Change	-88.5%	-12.45%	1.33%
Net Earnings / Revenue		-184.95%	-135.53%
Basic Earnings Per Share	-$0.27	-$0.49	-$0.37
Diluted Earnings Per Share	-$1.615M	-$4.463M	-$3.341M
COMMON SHARES
Basic Shares Outstanding	37.28M shares	37.16M shares	37.08M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q1	2018 Q1	2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$113.2M	$143.9M	$158.7M
YoY Change	-21.33%	21.74%	20.68%
Cash & Equivalents	$113.2M	$143.9M	$158.7M
Short-Term Investments
Other Short-Term Assets	$4.400M	$5.600M	$6.200M
YoY Change	-21.43%	-37.78%	5.08%
Inventory
Prepaid Expenses		$5.762M
Receivables
Other Receivables	$305.0K	$10.68M	$10.18M
Total Short-Term Assets	$118.3M	$160.2M	$175.5M
YoY Change	-26.17%	11.91%	4.5%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.520M	$4.700M	$5.091M
YoY Change	-25.11%	-27.31%	-25.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$10.99M	$20.54M	$5.231M
YoY Change	-46.47%	217.65%	-23.47%
TOTAL ASSETS
Total Short-Term Assets	$118.3M	$160.2M	$175.5M
Total Long-Term Assets	$10.99M	$20.54M	$5.231M
Total Assets	$129.3M	$180.7M	$180.7M
YoY Change	-28.48%	20.8%	3.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$896.0K	$5.300M	$9.256M
YoY Change	-83.09%	-44.89%	-59.55%
Accrued Expenses	$6.950M	$14.50M	$12.47M
YoY Change	-52.07%	-18.56%	-12.87%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$100.0K	$100.0K	$200.0K
YoY Change	0.0%	-50.0%	0.0%
Total Short-Term Liabilities	$8.872M	$20.00M	$22.03M
YoY Change	-55.64%	-28.5%	-41.88%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$100.0K	$100.0K
YoY Change	-100.0%	-50.0%	-66.67%
Other Long-Term Liabilities	$13.40M	$7.000M	$7.000M
YoY Change	91.43%	-1.41%	-1.41%
Total Long-Term Liabilities	$13.38M	$7.100M	$7.109M
YoY Change	88.45%	-2.7%	-3.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.872M	$20.00M	$22.03M
Total Long-Term Liabilities	$13.38M	$7.100M	$7.109M
Total Liabilities	$22.25M	$27.10M	$29.14M
YoY Change	-17.89%	-23.16%	-35.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$301.0M	-$237.4M	-$237.5M
YoY Change	26.8%	27.36%	43.47%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.449M		$1.142M
YoY Change			33.88%
Treasury Stock Shares	111.8K shares		58.57K shares
Shareholders Equity	-$49.73M	$138.0M	$151.6M
YoY Change
Total Liabilities & Shareholders Equity	$129.3M	$180.7M	$180.7M
YoY Change	-28.48%	20.8%	3.4%

Cashflow Statement

Concept	2019 Q1	2018 Q1	2017 Q4
OPERATING ACTIVITIES
Net Income	-$2.105M	-$18.31M	-$13.69M
YoY Change	-88.5%	-12.45%	1.33%
Depreciation, Depletion And Amortization	$8.000K	$334.0K	$300.0K
YoY Change	-97.6%	-7.22%	-50.0%
Cash From Operating Activities	-$2.186M	-$14.68M	-$17.20M
YoY Change	-85.1%	12.81%	1.18%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$100.0K	$100.0K
YoY Change	-100.0%
Cash From Investing Activities	$0.00	$83.00K	$100.0K
YoY Change	-100.0%	-738.46%	-150.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$32.00K	$155.0K
YoY Change	-79.35%	-10.92%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$46.00K	-$224.0K	55.20M
YoY Change	-79.46%	-1.75%	13700.0%
NET CHANGE
Cash From Operating Activities	-$2.186M	-$14.68M	-17.20M
Cash From Investing Activities	$0.00	$83.00K	100.0K
Cash From Financing Activities	-$46.00K	-$224.0K	55.20M
Net Change In Cash	-$2.186M	-$14.82M	38.10M
YoY Change	-85.25%	11.83%	-326.79%
FREE CASH FLOW
Cash From Operating Activities	-$2.186M	-$14.68M	-$17.20M
Capital Expenditures		$0.00	$0.00
Free Cash Flow		-$14.68M	-$17.20M
YoY Change		12.51%	1.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018	dei	Entity Registrant Name EntityRegistrantName	NEWLINK GENETICS CORP
CY2018	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2018	dei	Document Type DocumentType	10-K
CY2018	dei	Document Period End Date DocumentPeriodEndDate	2018-12-31
CY2018	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2018	dei	Amendment Flag AmendmentFlag	false
CY2018	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2018	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2018	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2018	dei	Entity Small Business EntitySmallBusiness	true
CY2018	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2018	dei	Entity Shell Company EntityShellCompany	false
CY2018	dei	Entity Central Index Key EntityCentralIndexKey	0001126234
CY2018	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37343547	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37168122	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37251220	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37109556	shares
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	92327	shares
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	58566	shares
CY2017	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	561000	USD
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2018Q2	dei	Entity Public Float EntityPublicFloat	137519199	USD
CY2019Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37276102	shares
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	11400000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	120738000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	158708000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5536000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6226000	USD
CY2018Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	339000	USD
CY2017Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	356000	USD
CY2018Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	459000	USD
CY2017Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	10176000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	127072000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	175466000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3727000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5091000	USD
CY2018Q4	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent	140000	USD
CY2017Q4	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent	140000	USD
CY2018Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3867000	USD
CY2017Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	5231000	USD
CY2018Q4	us-gaap	Assets Assets	130939000	USD
CY2017Q4	us-gaap	Assets Assets	180697000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	555000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9256000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8139000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12467000	USD
CY2018Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	56000	USD
CY2018Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2018Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	92000	USD
CY2017Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	92000	USD
CY2018Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	61000	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	160000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8847000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	22031000	USD
CY2018Q4	nlnk	Deferred Government Grants Obligations Noncurrent DeferredGovernmentGrantsObligationsNoncurrent	6000000	USD
CY2017Q4	nlnk	Deferred Government Grants Obligations Noncurrent DeferredGovernmentGrantsObligationsNoncurrent	6000000	USD
CY2018Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	43000	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	111000	USD
CY2018Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	906000	USD
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	998000	USD
CY2018Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	6949000	USD
CY2017Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	7109000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	15796000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	29140000	USD
CY2017Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2018Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	373000	USD
CY2017Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	372000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	407199000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	389786000	USD
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1417000	USD
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1142000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-291012000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-237459000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	115143000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	151557000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	130939000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	180697000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1206000	USD
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	390000	USD
CY2016	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3526000	USD
CY2018	us-gaap	Revenues Revenues	12474000	USD
CY2017	us-gaap	Revenues Revenues	28711000	USD
CY2016	us-gaap	Revenues Revenues	35768000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	45694000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	69866000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	93300000	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29218000	USD
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31726000	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33226000	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	74912000	USD
CY2017	us-gaap	Operating Expenses OperatingExpenses	101592000	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	126526000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-62438000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-72881000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-90758000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-102000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-126000	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	32000	USD
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	2029000	USD
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	616000	USD
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	237000	USD
CY2018	us-gaap	Interest Expense InterestExpense	52000	USD
CY2017	us-gaap	Interest Expense InterestExpense	119000	USD
CY2016	us-gaap	Interest Expense InterestExpense	22000	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1875000	USD
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	371000	USD
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	247000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-60563000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-72510000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-90511000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6968000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-559000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5356000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-53595000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-71951000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-85155000	USD
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.44
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.30
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.94
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	37191262	shares
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	31304309	shares
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	28979327	shares
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	195774000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16707000	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1679000	USD
CY2016	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	543000	USD
CY2016	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	82000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-85155000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	129466000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18508000	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	962000	USD
CY2017	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	445000	USD
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	19333000	USD
CY2017	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	289000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-71951000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	151557000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17120000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	143000	USD
CY2018	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	151000	USD
CY2018	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	275000	USD
CY2018	us-gaap	Cumulative Effect On Retained Earnings Net Of Tax1 CumulativeEffectOnRetainedEarningsNetOfTax1	42000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-53595000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	115143000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-53595000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-71951000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-85155000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	17120000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	18508000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	16707000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1145000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1407000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2084000	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	397000	USD
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2017	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2016	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3958000	USD
CY2018	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-102000	USD
CY2017	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-126000	USD
CY2016	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-226000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	305000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	965000	USD
CY2018	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-10223000	USD
CY2017	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-14350000	USD
CY2016	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	19139000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-13029000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-15469000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	24770000	USD
CY2018	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	17000	USD
CY2017	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	5479000	USD
CY2016	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-6834000	USD
CY2018	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-56000	USD
CY2017	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-335000	USD
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-68000	USD
CY2018	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	92000	USD
CY2017	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	91000	USD
CY2016	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	908000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-37939000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-48281000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-65947000	USD
CY2018	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	0	USD
CY2017	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	0	USD
CY2016	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	2180000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	43000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2246000	USD
CY2018	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	124000	USD
CY2017	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	254000	USD
CY2016	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	117000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	211000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-66000	USD
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2017	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	74416000	USD
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2018	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	294000	USD
CY2017	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1407000	USD
CY2016	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2222000	USD
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	275000	USD
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	289000	USD
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	82000	USD
CY2018	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	167000	USD
CY2017	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	246000	USD
CY2016	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	257000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-148000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	75288000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1883000	USD
CY2018	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-37970000	USD
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	27218000	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-64130000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	158708000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	131490000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	195620000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	120738000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	158708000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	131490000	USD
CY2018	us-gaap	Interest Paid InterestPaid	8000	USD
CY2017	us-gaap	Interest Paid InterestPaid	15000	USD
CY2016	us-gaap	Interest Paid InterestPaid	22000	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	25000	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	643000	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	1022000	USD
CY2018	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	7057000	USD
CY2017	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	6651000	USD
CY2016	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	197000	USD
CY2018	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
CY2017	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
CY2016	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	231000	USD
CY2018	us-gaap	Nature Of Operations NatureOfOperations	Description of Business Activities<div style="text-indent:22.5pt;text-align:justify;margin-top:12pt;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:Times New Roman;font-size:10pt;line-height:120%;">NewLink Genetics Corporation (NewLink) was incorporated as a Delaware corporation on June 4, 1999 and initiated operations in April of 2000.</span></div><div style="text-indent:24pt;text-align:justify;margin-top:8pt;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:Times New Roman;font-size:10pt;line-height:120%;">NewLink and its subsidiaries (the Company) are devoting substantially all of their efforts toward research and development. The Company has incurred significant losses in all years since being incorporated, except for the year ended December 31, 2014, and has never generated revenue from commercial sales of its drugs. </span></div><div style="text-indent:22.5pt;text-align:justify;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:Times New Roman;font-size:10pt;line-height:120%;">The accompanying financial statements as of and for the year ended December 31, 2018 have been prepared assuming the Company will continue as a going concern. The Company raised net proceeds of $37.6 million from its IPO, completed a follow-on offering of its common stock raising net proceeds of $49.0 million, and raised an additional $58.7 million in net proceeds from an at the market offering prior to March 31, 2015. </span></div><div style="text-indent:22.5pt;text-align:justify;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:Times New Roman;font-size:10pt;line-height:120%;">During 2017, the Company sold 1,940,656 shares of its common stock under an ATM offering, with aggregate net proceeds of $19.3 million after commissions of $398,000 paid to Cantor Fitzgerald & Co. (Cantor) as the placement agent, and other costs of $163,000. In October 2017, the Company sold 5,750,000 of its shares of common stock in a public offering for aggregate net proceeds of $55.2 million after underwriters' discounts, commissions and other expenses of $3.7 million. </span></div><div style="text-indent:22.5pt;text-align:justify;margin-top:9pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:Times New Roman;font-size:10pt;line-height:120%;">The Company's cash and cash equivalents are expected to be adequate to satisfy the Company's liquidity requirements through 2021. If available liquidity becomes insufficient to meet the Company’s operating obligations as they come due, the Company's plans include pursuing alternative funding arrangements and/or reducing expenditures as necessary to meet the Company’s cash requirements. However, there is no assurance that, if required, the Company will be able to raise additional capital or reduce discretionary spending to provide the required liquidity. Failure by the Company to successfully execute its plans or otherwise address its liquidity needs may have a material adverse effect on its business and financial position, and may materially affect the Company’s ability to continue as a going concern.</span></div>
CY2018	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-indent:13.5pt;text-align:justify;margin-top:9pt;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:Times New Roman;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="text-indent:24pt;text-align:justify;margin-top:9pt;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:Times New Roman;font-size:10pt;line-height:120%;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles, or U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	120700000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	158700000	USD
CY2018Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	998000	USD
CY2017Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	1100000	USD
CY2018Q4	us-gaap	Government Contract Receivable GovernmentContractReceivable	309000	USD
CY2017Q4	us-gaap	Government Contract Receivable GovernmentContractReceivable	9300000	USD
CY2018Q4	us-gaap	Government Contract Receivable Unbilled Amounts GovernmentContractReceivableUnbilledAmounts	0	USD
CY2017Q4	us-gaap	Government Contract Receivable Unbilled Amounts GovernmentContractReceivableUnbilledAmounts	465000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	653000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	653000	USD
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.25
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P36M
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	104000	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	271000	USD
CY2018	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents. Cash and cash equivalents are held by financial institutions and are federally insured up to certain limits. At times, the Company’s cash and cash equivalents balance exceeds the federally insured limits. To limit the credit risk, the Company invests its excess cash primarily in high quality securities such as money market funds.
CY2018	us-gaap	Revenues Revenues	12500000	USD
CY2017	us-gaap	Revenues Revenues	28700000	USD
CY2016	us-gaap	Revenues Revenues	35800000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	11400000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6226000	USD
CY2018Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5762000	USD
CY2017Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	10176000	USD
CY2018Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	10682000	USD
CY2017Q4	us-gaap	Assets Assets	180697000	USD
CY2018Q1	us-gaap	Assets Assets	180739000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	180697000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-237459000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-237417000	USD
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	180739000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	45694000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-53595000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-53595000	USD
CY2018	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-10223000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-13029000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-37939000	USD
CY2018Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	801000	USD
CY2017Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	801000	USD
CY2018Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	703000	USD
CY2017Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	652000	USD
CY2018Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	98000	USD
CY2017Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	149000	USD
CY2017Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	149000	USD
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1100000	USD
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1200000	USD
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1700000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1105000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1004000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	923000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	906000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	909000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	6570000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	11417000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10712000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11729000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6985000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6638000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3727000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5091000	USD
CY2018	nlnk	Common Stock Voting Rights Votesper Share CommonStockVotingRightsVotesperShare	1	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17100000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18500000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16700000	USD
CY2018Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	8300000	USD
CY2017	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2018	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2016	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2018Q4	nlnk	Sharebased Compensation Arrangementby Sharebased Payment Award Options Outstanding Intrinsic Value Per Share SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingIntrinsicValuePerShare	1.52
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2357	USD
CY2017	nlnk	Tax Cutsand Jobs Actof2017 Income Tax Expense Benefit TaxCutsandJobsActof2017IncomeTaxExpenseBenefit	-140000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-6968000	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-6968000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-6968000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6968000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-332000	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-140000	USD
CY2017	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-472000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-87000	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-87000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-419000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-140000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-559000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-6469000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1113000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	1113000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-5356000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5356000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	18165000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10622000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	28283000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	26327000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	14150000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	11780000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	300000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	327000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	680000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	789000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	17000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	15000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	39000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	417000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	297000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	62010000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	50198000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	62010000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	50198000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	62000000.0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	50200000	USD
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	11800000	USD
CY2017	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	15100000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3500
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3500
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.1007
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0003
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0088
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	-0.0120
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	-0.0736
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	-0.1588
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1820
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2410
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1207
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0016
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0280
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0025
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.1151
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0077
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0592
CY2018Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	82000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	335000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	653000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	653000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-53595000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-71951000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-85155000	USD
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	37191262	shares
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	361000	USD
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	31304309	shares
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	28979327	shares
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.44
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.30
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.94
CY2018	nlnk	Potential Milestone Expense PotentialMilestoneExpense	32000	USD
CY2017	nlnk	Potential Milestone Expense PotentialMilestoneExpense	1400000	USD
CY2016	nlnk	Potential Milestone Expense PotentialMilestoneExpense	2000000.0	USD
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	261000	USD
CY2018	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	303000	USD
CY2017	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	401000	USD
CY2016	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	482000	USD
CY2016	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	446000	USD
CY2018	us-gaap	Restructuring Charges RestructuringCharges	1300000	USD
CY2017Q3	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.50
CY2017	us-gaap	Restructuring Charges RestructuringCharges	1700000	USD
CY2017Q4	us-gaap	Restructuring Reserve RestructuringReserve	207000	USD
CY2018	us-gaap	Restructuring Charges RestructuringCharges	1323000	USD
CY2018	us-gaap	Payments For Restructuring PaymentsForRestructuring	881000	USD
CY2018	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	0	USD
CY2018Q4	us-gaap	Restructuring Reserve RestructuringReserve	649000	USD
CY2018Q1	us-gaap	Revenues Revenues	9900000	USD
CY2018Q2	us-gaap	Revenues Revenues	2252000	USD
CY2018Q3	us-gaap	Revenues Revenues	120000	USD
CY2018Q4	us-gaap	Revenues Revenues	202000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-18706000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-17748000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-15038000	USD
CY2018Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-10946000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-18310000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-17313000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-7403000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	-10569000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2017Q1	us-gaap	Revenues Revenues	2761000	USD
CY2017Q2	us-gaap	Revenues Revenues	10370000	USD
CY2017Q3	us-gaap	Revenues Revenues	5482000	USD
CY2017Q4	us-gaap	Revenues Revenues	10098000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-21198000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-16727000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-20905000	USD
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-14051000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-20913000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-16726000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-20626000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	-13686000	USD
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.72
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.57
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.69
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37

Files In Submission

Name	View Source	Status
0001126234-19-000026-index-headers.html	Edgar Link	pending
0001126234-19-000026-index.html	Edgar Link	pending
0001126234-19-000026.txt	Edgar Link	pending
0001126234-19-000026-xbrl.zip	Edgar Link	pending
a20181231q4-ex10254.htm	Edgar Link	pending
a20181231q4-ex10401.htm	Edgar Link	pending
a20181231q4-ex211.htm	Edgar Link	pending
a20181231q4-ex231.htm	Edgar Link	pending
a20181231q4-ex311.htm	Edgar Link	pending
a20181231q4-ex312.htm	Edgar Link	pending
a20181231q4-ex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nlnk-20181231.htm	Edgar Link	pending
nlnk-20181231.xsd	Edgar Link	pending
nlnk-20181231_cal.xml	Edgar Link	unprocessable
nlnk-20181231_def.xml	Edgar Link	unprocessable
nlnk-20181231_g1.jpg	Edgar Link	pending
nlnk-20181231_g2.jpg	Edgar Link	pending
nlnk-20181231_g3.jpg	Edgar Link	pending
nlnk-20181231_htm.xml	Edgar Link	completed
nlnk-20181231_lab.xml	Edgar Link	unprocessable
nlnk-20181231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LUMO
Lumos Pharma Inc Stock $lumo

2019 Q1 Form 10-K Financial Statement

#000112623419000026 Filed on March 05, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUMO Lumos Pharma Inc Stock $lumo

2019 Q1 Form 10-K Financial Statement

#000112623419000026 Filed on March 05, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUMO
Lumos Pharma Inc Stock $lumo